HCT CHART upward indication, page-788

As per announcement on 20/04/20. "Holista and GICC LLC have issued instructions to commence further tests on Path-Away® to assess its
efficacy against COVID-19 via the more rigorous direct inoculation method. This additional testing is being conducted at Biosafety Laboratory approved by the Centers for Disease Control (“CDC” ) of the United States. Results are expected to be released as soon as the testing procedure is completed based on the current work schedule." Now having just read that again it could be taken two ways. First they are testing directly against COVID-19 or they are doing a different sort of test against the Feline Coronavirus to just test efficiency. Like a lot of their announcements it's written badly which creates confusion. I think management could probably run a corner store but they are not up to task for an ASX listed public company.